Jimini Health Launches with $8M Seed Funding to Advance Mental Health Care
Stanford-based Jimini Health, a mental health startup founded in 2023, has announced its official launch with $8 million in seed …
News
Axsome Therapeutics Announces Positive Phase 3 Results for Reboxetine in Narcolepsy
Axsome Therapeutics announced that its investigational treatment, AXS-12 (reboxetine), met the primary endpoint in the ENCORE Phase 3 trial. The …
Novo Holdings Supports $135 Million Funding to Advance Adcendo’s Antibody-Drug Conjugate Development
Novo Holdings has joined a $135 million Series B financing round for Adcendo, a clinical-stage biotechnology company headquartered in Copenhagen, …
Valence Labs and Recursion Launch OpenQDC: The Largest Public Quantum Mechanical Dataset for ML Research
Researchers at Valence Labs, powered by Recursion, have introduced OpenQDC (Open Quantum Data Commons), an extensive, publicly accessible quantum mechanical …
Roche Expands Cell Therapy Portfolio with $1.5 Billion Poseida Therapeutics Acquisition
Swiss pharmaceutical giant Roche has announced its acquisition of Poseida Therapeutics, a San Diego-based biotech company specializing in next-generation cell …
A New Genetic Insight into Mitochondrial DNA Depletion Syndrome
Japanese researchers have identified a novel genetic cause for hepatocerebral mitochondrial DNA depletion syndrome (MTDPS), linking it to variants in …
Communication, Staffing, Technology: The Persistent Barriers in Clinical Trials
Today, we’re diving into the results of Advarra’s 2024 Site-Sponsor-CRO Collaboration Survey, which highlights three major barriers hindering collaboration in …
M42 CEO Hasan Jasem Al Nowais Calls for a Global Shift Toward Preventative Healthcare
At the 7th Annual Longevity Forum in London, Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, delivered …
Lantern Pharma Expands Phase 2 Harmonic Clinical Trial to Japan and Taiwan
Lantern Pharma (NASDAQ: LTRN) has dosed the first patient in Japan as part of the expansion of its Phase 2 …
Cradle Raises $73M for Gen-AI Protein Engineering
Cradle has secured $73 million in a Series B funding round led by IVP, bringing its total funding to over …
LongeVC Announces Investment in Glyphic Biotechnologies, Developing Single-Molecule Protein Sequencing
LongeVC has announced its investment in Glyphic Biotechnologies, a company developing single-molecule protein sequencing technology.
Trogenix Emerges from Stealth with Precision Gene Therapy Platform to Target Aggressive Cancers
Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.